Navigation Links
Lupin Gets USFDA Approval for Meloxicam

Lupin Ltd today said it has got the approval of US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Meloxicam tablets used in the treatment of osteoarthritis and rheumatoid arthritis. //

The approval is for Meloxicam tablets of strengths of 7.5 mg and 15 mg , the company informed the Bombay Stock Exchange.

"The approval of our Meloxicam ANDA further reinforces Lupin's ability on submitting high quality dossiers and gaining approval in time. Our thorough execution has enabled us to launch the product immediately," Lupin Managing Director Kamal K Sharma said.

Meloxicam is a generic equivalent of Boehringer Ingelheim's non-steroidal anti-inflammatory drug (NSAID), Mobic. Its sales in the US were approximately 1.1 billion dollars for the 12-month period ended December 2005 according to IMS Health, it added.

This is the company's 14th ANDA approval from US FDA, it said.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Lupin flour may cause peanut allergy like reactions
2. Lupin Gets USFDA Approval For Quinapril Tablets
3. US Court Rules Against Lupin in Ramipril Patent Case
4. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
5. Lupin Gets Tentative Nod from FDA for Antidepressant Drug
6. Morepan to file new drug applications with the USFDA
7. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
8. Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
9. Lupin Gets USFDA Approval For Quinapril Tablets
10. Ranbaxy Gets USFDA Nod For Simvastatin
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: